OSPred Tool: A Digital Health Aid for Rapid Predictive Analysis of Correlations Between Early End Points and Overall Survival in Non-Small-Cell Lung Cancer Clinical Trials.
Khader ShameerYouyi ZhangAndrzej ProkopSreenath NampallyImran Khan A NJim WeatherallRenee Bailey IaconaFaisal M KhanPublished in: JCO clinical cancer informatics (2022)
The OSPred tool offers interactive visualization of clinical trial end point correlations with reference to a large pool of historical NSCLC studies. Its focused capability has the potential to digitally transform and accelerate data-driven decision making as part of the drug development process.
Keyphrases
- clinical trial
- decision making
- phase ii
- small cell lung cancer
- public health
- healthcare
- open label
- mental health
- double blind
- human health
- study protocol
- phase iii
- advanced non small cell lung cancer
- health information
- free survival
- randomized controlled trial
- loop mediated isothermal amplification
- case control
- social media
- health promotion
- tyrosine kinase
- climate change
- quantum dots
- brain metastases